Benefits
Cholesterol and LDL levels
A review of 24 lecithin studies found no evidence that lecithin lowers cholesterol beyond the linoleic acid it contains, and in healthy volunteers 22.5 g a day for 4 weeks left total cholesterol unchanged. In the best controlled positive study the plant stanols, not the lecithin vehicle, likely explain the 14.3% LDL drop. Reported LDL drops of 42% to 56% on 500 mg a day in one small study have not been matched by the others.
Triglyceride levels
In 10 healthy volunteers, 7.5 g of soy lecithin three times a day for 4 weeks produced a small but significant drop in triglycerides and total phospholipids, with no change in total cholesterol. In 47 people with type 2 diabetes and high blood fats, 15 g a day of a mix with more soy protein (35%) than lecithin (12%) lowered triglycerides by 22% over 12 weeks.
Choline supply for acetylcholine
Phosphatidylcholine in lecithin supplies choline, which the body uses to make acetylcholine (a neurotransmitter involved in memory), and it is a building block of cell membranes. That is biochemistry, not a demonstrated effect. None of the studies cited on this page measured memory, attention or any other thinking outcome, so any cognitive claim for lecithin is unproven here.
Phosphatidylcholine and liver fat export
Phosphatidylcholine is a major part of cell and lipoprotein membranes, and the liver uses it to package fat for export into the blood. None of the studies cited on this page measured a liver outcome, so this is background biology rather than a demonstrated benefit of taking lecithin.
HDL maturation and the LCAT enzyme
Phosphatidylcholine is the substrate for an enzyme called LCAT, which helps HDL particles mature and carry cholesterol back to the liver. This is textbook biochemistry about the phospholipid your body already carries, and no study cited here tested whether swallowing lecithin changes it. There is no clinical evidence on this page that lecithin supplements improve HDL function.
Mechanism of action
Reverse Cholesterol Transport (LCAT Substrate)
Phosphatidylcholine in HDL particles is the substrate for LCAT, which esterifies cholesterol and enables HDL's role as a cholesterol acceptor. The phospholipid coat of HDL is largely phosphatidylcholine, and that is needed for HDL to mature. This describes phosphatidylcholine that is already in the body; it is not evidence that a lecithin supplement changes the process.
Cholesterol Absorption Reduction
Phospholipids in the intestinal lumen compete with cholesterol for incorporation into mixed micelles, reducing intestinal cholesterol absorption. The one cited human measurement of reduced cholesterol absorption used lecithin combined with plant stanols, and plant stanols block cholesterol absorption on their own, so that result cannot be credited to the lecithin.
Membrane Phospholipid Replenishment
Phosphatidylcholine is one of the two major phospholipids the body makes from choline for its cell membranes. In one cited study in people with type 2 diabetes, a soy protein and lecithin mix shifted the fatty acid makeup of red blood cell phospholipids, but plain lecithin has not been tested for this.
Choline Provision for Acetylcholine Synthesis
Lecithin is broken down to release choline, which the body uses to make acetylcholine, a neurotransmitter involved in memory. This is why lecithin gets called a brain food, but nothing cited on this page measured cognition, so a cognitive benefit is unproven here.
VLDL Assembly and Secretion
Hepatic phosphatidylcholine is essential for proper VLDL particle assembly and secretion. In animals, a shortage of phosphatidylcholine leads to fat building up in the liver. That animal finding is the traditional reason people take lecithin for the liver. It is not the same as showing that a supplement improves liver health in humans, and no study cited here measured a liver outcome.
Clinical trials
Small study described as double blind: 500 mg of soy lecithin or a soy oil placebo daily, with blood fats compared before and after within each group rather than between groups. (Mourad et al. 2010, Cholesterol)
30 adults aged 58 to 70 already diagnosed with high cholesterol; 20 took lecithin, the rest placebo, for up to 2 months.
The authors reported total cholesterol down 40.66% and 42.00% and LDL down 42.05% and 56.15% after 1 and 2 months. Treat these figures with caution: the groups were small, lecithin was not compared with placebo directly, and the drops are far larger than in the other lecithin studies cited here.
10 week, randomized, double blind parallel trial of soy stanol and lecithin powder versus the lecithin vehicle three times daily for the last 4 weeks, with cholesterol absorption measured in paired meal tests. (Spilburg et al. 2003, J Am Diet Assoc)
45 adults with normal or mildly high cholesterol: 21 in the absorption tests and 24 in the 4 week cholesterol trial.
Stanol and lecithin powder reduced cholesterol absorption by 32.1% to 38.2% in paired meal tests. In the 4 week phase, total cholesterol fell 10.1% and LDL 14.3% (n=24). Plain lecithin was only the vehicle and comparator, and plant stanols lower cholesterol on their own, so this result is evidence for stanols, not for lecithin.
Before and after study of 7.5 g soy lecithin three times daily (22.5 g a day) for 4 weeks added to the usual diet, with plasma and bile lipids measured. (Cobb et al. 1980, Nutr Metab)
10 healthy volunteers (4 men, 6 women).
Total plasma cholesterol and cholesterol esterification did not change. Triglycerides and total phospholipids fell slightly but significantly, and bile composition was unchanged. A very small study with no control group, but it tested lecithin alone at more than ten times a typical supplement dose.